RMEA Stock Overview
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for RMEA from our risk checks.
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$22.40 |
| 52 Week High | US$23.60 |
| 52 Week Low | US$13.70 |
| Beta | 0.69 |
| 11 Month Change | 1.82% |
| 3 Month Change | 12.56% |
| 1 Year Change | 61.15% |
| 33 Year Change | 0.90% |
| 5 Year Change | 67.16% |
| Change since IPO | 576.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| RMEA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.8% | -0.4% | -0.4% |
| 1Y | 61.2% | -7.1% | 7.1% |
Return vs Industry: RMEA exceeded the German Medical Equipment industry which returned -6.1% over the past year.
Return vs Market: RMEA exceeded the German Market which returned 7.8% over the past year.
Price Volatility
| RMEA volatility | |
|---|---|
| RMEA Average Weekly Movement | 3.9% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RMEA has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: RMEA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 9,980 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
ResMed Inc. Fundamentals Summary
| RMEA fundamental statistics | |
|---|---|
| Market cap | €33.15b |
| Earnings (TTM) | €1.06b |
| Revenue (TTM) | €4.56b |
31.9x
P/E Ratio7.4x
P/S RatioIs RMEA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMEA income statement (TTM) | |
|---|---|
| Revenue | US$4.81b |
| Cost of Revenue | US$2.00b |
| Gross Profit | US$2.80b |
| Other Expenses | US$1.69b |
| Earnings | US$1.11b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.58 |
| Gross Margin | 58.33% |
| Net Profit Margin | 23.15% |
| Debt/Equity Ratio | 13.0% |
How did RMEA perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield26%
Payout RatioDoes RMEA pay a reliable dividends?
See RMEA dividend history and benchmarks| ResMed dividend dates | |
|---|---|
| Ex Dividend Date | Nov 06 2024 |
| Dividend Pay Date | Dec 12 2024 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 20 days |
Does RMEA pay a reliable dividends?
See RMEA dividend history and benchmarks